Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Innovations in Pharmacy|May 21, 2021
Cultivating a Community of Practice through PodcastingGregory M Zumach, Edward PortilloCurrents in Pharmacy Teaching & Learning|April 11, 2020
Application of Absorb-Do-Connect learning framework to foster experiential, practice, and career-ready learnersEdward Portillo, Casey E GallimoreInnovations in Pharmacy|May 21, 2021
Intentional Application of the Taba Curriculum Model to Develop a Rural Pharmacy Practice CourseEdward Portillo, Kevin Look, Dave Mott, et al.Innovations in Pharmacy|March 15, 2024
Student Pharmacist Led Fish Oil Deprescribing Initiative at a Veterans Affairs Hospital and Rural ClinicsMaria Wopat, Federick Dunkerson, Alissa Moss, et al.Journal of the American Pharmacists Association : Japha|January 12, 2021
A state-level needs analysis of community pharmacy point-of-care testingCasey E Gallimore, Andrea L Porter, Susanne G Barnett, et al.Journal of the American Pharmacists Association : Japha|March 12, 2021
Illustrating access to community pharmacies in WisconsinKevin A Look, Courtney Dekeyser, Sarah Conjurske, et al.Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS studyKristin A Evans, Michael Pollack, Edward Portillo, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 18, 2022
PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD ExacerbationJoseph Tkacz, Kristin A Evans, Daniel R Touchette, et al.Innovations in Pharmacy|January 11, 2023
Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural VeteransSonia Bhardwaj, Stephanie Garvin, Sierra Kuehl, et al.Current Medical Research and Opinion|August 11, 2025
Prompt initiation of single-inhaler budesonide/glycopyrrolate/formoterol fumarate (BGF) following a COPD exacerbation reduces exacerbations and cardiopulmonary risk in patients with COPD: insights from the MITOS EROS+CP study in the United StatesMichael Pollack, Joseph Tkacz, Jill Schinkel, et al.Pageof 2